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SpoIIE is a dual function protein that plays important
roles during sporulation in Bacillus subtilis. It binds to
the tubulin-like protein FtsZ causing the cell division
septum to relocate from mid-cell to the cell pole, and it
dephosphorylates SpoIIAA phosphate leading to estab-
lishment of differential gene expression in the two com-
partments following the asymmetric septation. Its 872
residue polypeptide contains a multiple-membrane span-
ning sequence at the N-terminus and a PP2C phosphatase
domain at the C-terminus. The central segment that
binds to FtsZ is unlike domains of known structure or
function, moreover the domain boundaries are poorly
defined and this has hampered the expression of soluble
fragments of SpoIIE at the levels required for structural
studies. Here we have screened over 9000 genetic con-
structs of spoIIE using a random incremental truncation
library approach, ESPRIT, to identify a number of
soluble C-terminal fragments of SpoIIE that were aligned
with the protein sequence to map putative domains and
domain boundaries. The expression and purification of
three fragments were optimised, yielding multimilligram
quantities of the PP2C phosphatase domain, the putative
FtsZ-binding domain and a larger fragment encompass-
ing both these domains. All three fragments are mono-
meric and the PP2C domain-containing fragments have
phosphatase activity.
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Introduction
The formation of spores by Bacillus subtilis is an extreme
response to starvation and a primitive system of cell
differentiation. During sporulation, the cell divides asymme-
trically to produce a larger mother cell and a smaller fore-
spore (Fig. 1A). The mother cell later engulfs the forespore
and nurtures it as it develops into a resistant spore. Although
the mother cell and the forespore contain identical chromo-
somes, they follow different programmes of gene expression
and have different fates (Errington, 2003; Hilbert and Piggot,
2004). This is brought about by the sequential activation of
four compartment-specific sigma factors that direct RNA
polymerase to distinct sets of promoters. The forespore-
specific sF is the first of these to be activated. Although it is
present in the pre-divisional cell and it partitions into both
compartments, sF becomes active only after the formation of
the polar septum and only in the forespore.
sF (SpoIIAC) activity is governed by a complex interplay
with three other proteins, SpoIIAB and SpoIIAA encoded on
the three cistron spoIIA operon, and SpoIIE. SpoIIAB is an
anti-sigma factor that forms a tight complex with sF and pre-
vents the latter from combining with core RNA polymerase
and initiating transcription. It is also a protein kinase that
phosphorylates SpoIIAA on a conserved serine. The phos-
phorylation state of SpoIIAA, which is an anti-sigma factor
antagonist, is the arbiter of cell fate. In the pre-divisional cell
and the mother cell following asymmetric septation,
SpoIIAA is phosphorylated and sF is sequestered as the
sF:SpoIIAB2 complex in which it is inactive (Fig. 1A). In
the forespore compartment, SpoIIAAP becomes depho-
sphorylated, and thereby activated, by a specific phosphatase,
SpoIIE. Unphosphorylated SpoIIAA displaces sF from the
sF:SpoIIAB2 complex (Campbell et al., 2002; Carniol et al.,
2004; Masuda et al., 2004). Relieved of SpoIIAB inhibition,
sF can combine with core RNA polymerase and activate
expression of forespore-specific sporulation genes.
SpoIIE is also involved in switching the site of assembly
of the cell division apparatus from mid-cell during normal
cell division to a polar location during sporulation (Khvorova
et al., 1998). This switch involves the migration of the
tubulin-like protein, FtsZ, which initially forms a ring
(termed the Z-ring) at mid-cell to sites near to the cell poles.
Z-ring migration requires a sporulation-specific increase in
the levels of FtsZ and expression of spoIIE (Khvorova et al.,
1998; Ben Yehuda and Losick, 2002). SpoIIE localises to the
two polar sites of the cell in the form of rings (the E-rings)
(Arigoni et al., 1995; Barak et al., 1996; Levin et al., 1997).
SpoIIE helps to stabilise the Z-ring at these positions and
one of these E/Z-rings matures into the asymmetric septum.
The precise role of SpoIIE in polar Z-ring (re)assembly and
asymmetric cell division is not known, although the implied
interaction between SpoIIE and FtsZ is supported by data
from yeast two-hybrid screens and assays of the purified
components (Lucet et al., 2000).
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The interplay of SpoIIE, FtsZ and SpoIIAAP serves to
couple the morphological event of polar septation to the acti-
vation of sF and compartment-specific gene expression.
How, having localised to the site of asymmetric septation,
SpoIIE brings about activation of sF in the forespore, but
not in the mother cell, has been a subject of much conjec-
ture, with models based on differential membrane localis-
ation and genetic asymmetry having been proposed (Wu
et al., 1998; Frandsen et al., 1999; Pan et al., 2001). It has
been shown however that an imbalance in the activity of
SpoIIE resulting from the (10-fold) volume difference
between the compartments can account for differential regu-
lation (Clarkson et al., 2004; Iber et al., 2006).
The structures of the SpoIIA proteins are known (Kovacs
et al., 1998; Seavers et al., 2001; Campbell et al., 2002;
Masuda et al., 2004). These structures define the active and
inactive (phosphorylated) forms of SpoIIAA and the inter-
actions of SpoIIAB with sF and SpoIIAA. What is missing
is structural insight into SpoIIE and its interactions with
SpoIIAA and FtsZ. The 827 residues of B. subtilis SpoIIE
are arranged in three functional domains (Fig. 1B). Domain I
at the N-terminus contains 10 putative membrane-spanning
segments (Arigoni et al., 1999). A large central domain II is
involved in protein–protein interactions between SpoIIE sub-
units and with the cell division protein FtsZ (Khvorova
et al., 1998; Lucet et al., 2000). The C-terminal domain III
possesses the SpoIIAAP phosphatase activity (Duncan
et al., 1995).
SpoIIE and fragments thereof have been purified in low
quantities (i) using an intein-chitin-binding domain fusion
system or (ii) following refolding from inclusion bodies
allowing biochemical characterisation of the molecule (Lucet
et al., 2000). Increasing the expression levels to the multi-
milligram levels required to initiate and sustain structural
analyses has proved difficult. We reasoned that the poor defi-
nition of the domain structure was a factor militating against
the high level expression of stable and soluble protein.
Domain I is defined by the pattern of hydrophobic residues
and topology analysis (Arigoni et al., 1999), and domain III
is defined by homology to PP2C type phosphatases.
However, the domain boundaries are imprecise. Domain II
has no recognisable motifs or homology to proteins of
known structure. To define the domain boundaries in SpoIIE
with greater precision, we adopted a truncation library muta-
genesis approach using a recently developed method,
ESPRIT (expression of soluble proteins by random incremen-
tal truncation; Tarendeau et al., 2007; Yumerefendi et al.,
2010). In ESPRIT, a comprehensive, oversampled gene del-
etion library is constructed in which terminally truncated
coding sequences are generated by exonuclease III deletion
and fused to a sequence encoding a C-terminal biotin accep-
tor peptide (Beckett et al., 1999). This tag is efficiently bioti-
nylated in vivo by the endogenous Escherichia coli BirA
enzyme and biotinylation levels can be measured by fluor-
escent streptavidin binding to robotically prepared colony
blots. In the first screening step, ranking of clones permits
enrichment of putative soluble clones from the library since
the biotinylation reaction is more efficient when the target
protein is soluble. In the second step, the solubility and pur-
ifiability are confirmed by purification screening using an
N-terminal hexahistidine tag.
The ESPRIT method has been successfully applied to a
number of challenging targets that had previously resisted
soluble expression, most notably the PB2 subunit of influ-
enza virus RNA polymerase (Tarendeau et al., 2007;
Guilligay et al., 2008; Tarendeau et al., 2008). Here we
describe the truncation mutagenesis and screening of SpoIIE
leading to the generation of previously unidentified, highly
soluble and enzymatically active domains that are purifiable
at a quality and quantity suitable for structural and functional
studies.
Materials and methods
Subcloning of the SpoIIE gene
The spoIIE-coding sequence was cloned into a pET11a
plasmid derivative. A silent mutation of the Ala433 codon
from GCA to GCG was introduced by site-directed mutagen-
esis using the Quikchange (Stratagene) system to remove an
NsiI restriction endonuclease cleavage recognition site
(ATGCAT). The mutated plasmid was used as template for
the PCR amplification of a fragment of the spoIIE-coding
sequence encompassing base pairs 901–2481. The primers
used were spoIIE901F 50-GATCCT AGGGCG CGCCGC
CGGTCT GATGAC AACGCT CTATGA GTCAT-30 and
spoIIE2481R 50-CTAGGA TCATGC ATTTGA AATTTC
TTGTTT GTTTTG AAAGAT TGCCGG-30 (where the
underlined bases are restriction endonuclease cleavage recog-
nition sequences). The resulting 1612 bp fragment was
digested with NsiI and AscI and ligated to the similarly
digested pET9a-derived plasmid, pTAR010 (Tarendeau
et al., 2008). The ligation products were introduced into
competent E.coli Novablue cells and kanamycin-resistant
transformants harbouring the plasmid pTAR-spoIIE, in
which codons 301–827 are fused in-frame to sequences
encoding a TEV protease cleavable hexahistidine tag
(MGHHHHHHDYDIPTTENLYFQG) at the N-terminus and
a biotin acceptor peptide (SNNGSGGGLNDIFEAQKIEW
HE) at the C-terminus, were identified.
Fig. 1. Asymmetric cell division and the role of SpoIIE. (A) In the
pre-divisional cell (upper) and the mother cell (MC) following cell division
(lower), SpoIIAA (AA) is phosphorylated and sF is in a complex with
SpoIIAB (AB2). In the forespore (FS), s
F is free and AA and AB are in
complex. SpoIIE (E) accumulates at the asymmetric septum, a double
membrane structure. (B) The putative three domain structure of SpoIIE. The
limits of the putative FtsZ-binding domain are uncertain.
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Construction of the spoIIE deletion library
Ten micrograms of pTAR-spoIIE plasmid DNA was cleaved
upstream of the 50-end of the inserted spoIIE sequence with
AatII. Having established by gel electrophoretic analysis that
the DNA had been efficiently linearised, the plasmid was
further digested with AscI yielding a DNA fragment with a
50 AscI end, which is sensitive to exonuclease III, and a 30
AatII end that is insensitive to the action of this enzyme.
Four micrograms of the pTAR-spoIIE fragment was digested
with 400 units of exonuclease III (New England Biolabs,
NEB) in 120 ml of NEB Buffer 1 supplemented with 50 mM
NaCl. The reaction mixture was incubated at 228C and, to
ensure an even distribution of fragments, 2 ml aliquots were
withdrawn each minute and quenched by addition to a tube
containing 200 ml of ice cold 3 M NaCl. The sample was
then heated to 708C to denature the exonuclease III and salt
was removed by passage through a Nucleospin Extract II
column (Macherey Nagel). As exonuclease III removes
mononucleotides stepwise from recessed 30 termini, the pro-
ducts of the digestion reaction have 50 overhangs of varying
lengths. To remove single-stranded overhangs, the DNA in a
reaction volume of 50 ml was treated with 5 units of mung
bean nuclease in its cognate buffer (NEB) at 308C for
30 min. The DNA was repurified using the Nucleospin
Extract II kit and treated with 1 unit of Pfu polymerase,
2 mM dNTPs in 50 ml of Pfu polymerase buffer for 20 min
at 708C to ensure that the products were blunt ended.
The complete reaction mix was loaded onto a 0.5%
agarose gel and the products were resolved by electrophor-
esis. With reference to suitable molecular weight markers,
two slices of the gel were excised containing DNA fragments
with expected truncations of approximately 0–750 and 750–
1500 bp. These will be referred to as the ‘large’ and ‘small’
clone sublibraries, respectively. The linear DNA extracted
from the agarose slices, was circularised using T4 DNA
ligase and a 2 ml aliquot of the ligation products was mixed
with 50 ml competent E.coli Omnimax cells (Invitrogen).
After incubation on ice for 5 min, 428C for 30 s and on ice
for a further 5 min, the cells were allowed to recover in 1 ml
of super optimal broth with catabolite repression medium at
378C in a shaker incubator. One hundred microlitres of the
cell suspension was plated onto solid LB media and
kanamycin-resistant transformants were isolated. The plas-
mids from 12 colonies were purified and analysed for insert
size to assess the quality of the library. The remaining por-
tions of the stored transformation mixes were each plated
onto six LB-kanamycin plates. Following overnight incu-
bation and colony growth, 1 ml of liquid LB medium was
placed on the surface of each plate and a glass spreader was
used to gently resuspend the cells. The six cell suspensions
from each library were pooled and plasmid DNA was
extracted and purified using a Qiagen miniprep kit employing
three spin columns per library. The two supercoiled plasmid
DNA preparations were used to transform competent E.coli
BL21 (DE3) RIL for expression screening.
Processing of the spoIIE truncation library
A volume of the transformation mixture sufficient to generate
approximately 4000 colonies per plate was spread onto
LB-agar kanamycin (30 mg ml21)/chloramphenicol
(100 mg ml21) media prepared in square Q-trays (Genetix,
UK) and colonies were allowed to grow overnight at 378C.
Colonies were picked from the Q-trays using a Kbiosystems
colony picking robot and used to inoculate media in
384-well plates containing 70 ml Terrific Broth (TB) medium
with 30 mg ml21 kanamycin and 100 mg ml21 chlorampheni-
col. Sixteen plates were filled from the small subclone
library and eight from the large subclone library. Plates were
shaken overnight at 300 rpm for 20 h at 308C.
Using the same robot, samples from the 384-well cultures
were arrayed onto 22 cm square nitrocellulose membranes
(Amersham) on LB agar plates supplemented with antibiotics
as above, according to a 3  3 gridding scheme in which
each sample was present in duplicate. Colonies were devel-
oped on the membrane during overnight incubation at 308C.
Expression of recombinant protein was induced by transfer-
ring the membrane onto identical medium, supplemented
with 0.1 mM isopropyl-b-D-thiogalactose and 50 mM biotin
with a further 4 h incubation at 308C.
Screening step 1: enrichment from the library of clones
expressing putatively soluble SpoIIE fragments
The nitrocellulose membrane was lifted from the Q-tray and
placed first onto Whatman filter paper saturated with lysis
solution (0.5 M NaOH, 1.5 M NaCl) for 10 min and sub-
sequently onto filter paper soaked in neutralisation solution
(1.5 M Tris pH 7.5, 1.5 M NaCl) for 3  5 min. Cell debris
was washed from the membrane by gentle scraping in 2
SSC solution (17.5 g NaCl, 8.8 g trisodium citrate, pH 7.0
per litre of water) and the membranes were incubated over-
night at 48C in Superblock (Pierce). The membranes were
washed in PBS-T buffer (NaCl/Pi with 0.2% Tween-20) and
incubated for 1 h at 48C with a monoclonal antibody against
hexahistidine (Amersham; 1:3000 in PBS-T buffer). The
membrane was extensively washed with PBS-T buffer and
then suspended in PBS-T buffer containing a secondary
mouse antibody conjugated to Alexa532 (Invitrogen) and
steptavidin conjugated to Alexa488 (Invitrogen) at dilutions
of 1:1000 and 1:5000, respectively. After a 1 h incubation at
48C, the membranes were washed in PBS-T buffer and then
with distilled water. The fluorescent signals were visualised
and recorded with a Typhoon Trio imager (GE healthcare)
using lasers tuned to excitation wavelengths of 488 and
532 nm to quantify the biotin and hexahistidine signals,
respectively.
Screening step 2: purification analysis of isolated SpoIIE
expression clones
Clones with clearly visible hexahistidine signals were ranked
according to their biotinylation signal intensity (as a marker
for soluble expression) and the top 96 clones were analysed
for their insert size by PCR using T7 forward and T7 reverse
primers and and 1 ml of cell culture as template. The PCR
products were analysed by agarose gel electrophoresis.
Expression testing was also carried out on the 96 clones.
Four milllitre cultures in the TB medium, supplemented
with antibiotics as before, were grown by shaking in
24-well plates and the expression of recombinant protein
was induced by the addition of IPTG to 1 mM at 248C
overnight. As described previously (Angelini et al., 2009),
cells were lysed using a sphaeroplast method and a Tecan
liquid handling robot facilitated purification using a
96-well filter plate containing Ni2þ-nitriloacetic acid resin.
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After washing the resin, the bound protein was eluted in
buffer containing 300 mM imidazole. The eluted protein
samples were analysed by SDS-polyacrylamide gel
electrophoresis.
Protein purification
The B10 and B2–B1-expressing cells harbour pET-YSBLIC-
3C derivative plasmids (Fogg and Wilkinson, 2008) contain-
ing the subcloned coding sequences of SpoIIE(590–827) and
SpoIIE(375–595), respectively linked to a sequence encod-
ing an N-terminal MSSGHHHHHH tag with a human
rhinovirus (HRV) 3C protease cleavage site.
Half litre cultures of E.coli BL21 (DE3) harbouring plas-
mids encoding the B2 (SpoIIE(375–827)), H1 (SpoIIE(412–
827)), B10 (SpoIIE(590–827)) and B2–B1 (SpoIIE(375–595))
fragments were grown at 378C until the OD600 reached 0.6–
0.8. Production of recombinant protein was induced by the
addition of IPTG to 1 mM and growth with shaking was con-
tinued at 168C overnight for the B2, H1 and B2–B1 expressing
cells or at 378C for 4 h for the B10-expressing cells. The cells
were harvested by centrifugation and resuspended in 25 ml of
50–100 mM Tris–HCl pH 8.2, 50 mM NaCl, (buffer A) in the
presence of Roche protease inhibitor cocktail. One hundred
millimolar urea was included in the buffers used for purifi-
cation of the B2 fragment. The cells were lysed by sonication
and the extracts were fractionated by metal chelation chromato-
graphy on a HiTrap column charged with nickel. The SpoIIE
fragments were highly enriched in successive fractions
eluting from this column at circa 250 mM imidazole in yields
of 10–15 mg. The affinity tags were removed by proteolytic
cleavage (either TEV or HRV-3C) followed by a second
passage through the HiTrap column and fractionation on an
Superdex S200 16/60 gel filtration column (GE Biosciences)
equilibrated in buffer A.
Phosphatase assay
SpoIIAA-phosphate phosphatase assays of the SpoIIE frag-
ments were performed with recombinant SpoIIAA from
Bacillus sphaericus. SpoIIAA was prepared from E.coli cul-
tures expressing spoIIAA and SpoIIAAP was prepared from
cells co-expressing spoIIAA and spoIIAB as described pre-
viously (Seavers et al., 2001). The SpoIIE fragments were
mixed with 1.6 nmol SpoIIAAP at a molar ratio of either
1:100 or 1:400 in a 10 ml volume of 50 mM Tris pH 8.2 and
100 mM NaCl containing 10 mM MnCl2 and the reaction was
allowed to proceed for 30 min at 308C. Ten microlitres of
loading dye was added to the sample and the reaction products
were analysed by gel electrophoresis in 8.75% polyacrylamide
gels under non-denaturing conditions. Gels were run at 100 V
for 120 min and stained with Coomassie blue dye.
SEC-MALLS
For determination of the oligomeric state of the proteins, the
SpoIIE fragments were analysed using a HPLC-MALLS
apparatus. Protein of 0.1 ml samples at 1 mg ml21 were
loaded onto a Superdex 200, 10/300 gel filtration column
equilibrated at 0.5 ml min21 with a mobile-phase consisting
of 50 mM Tris–HCl and 150 mM sodium chloride at pH 8.0.
The eluate was passed successively through a SPD20A UV/
Vis detector, a Wyatt Dawn HELEOS-II 18-angle light scat-
tering detector and a Wyatt Optilab rEX refractive index
monitor with the system driven by a Shimadzu HPLC system
comprising an LC-20AD pump. The data were processed and
molecular masses calculated using the Astra V software
(Wyatt).
FtsZ-binding assay
Bacillus subtilis FtsZ was isolated and purified as described
previously using the E.coli expression strain W3110 (Wang
and Lutkenhaus, 1993). Purified SpoIIE(412–827),
SpoIIE(590–827) and FtsZ were dialysed overnight at 48C
into buffer D (150 mM NaCl, 50 mM Tris–HCl pH 7.5).
FtsZ-binding assays were performed by mixing FtsZ with
SpoIIE(412–827) and SpoIIE(590–827) samples. Ten micro-
litres of SpoIIE(412–827) or SpoIIE(590–827) at
0.7 mg ml21 was mixed with 10 ml of 0.7 mg ml21 FtsZ in
the presence of 1 mM GTP and 10 mM MnCl2 and incubated
on ice for 1 h. Glycerol was added to the samples to a final
concentration of 20% and samples were subjected to non-
denaturing 8.75% PAGE. The gel was stained with
Coomassie blue to visualise the protein species.
Results
Library construction
An exonuclease III, mung bean nuclease truncation strategy
was applied to a cloned 1581 bp fragment of spoIIE-
encoding residues 300–827 of SpoIIE which comprise the
C-terminus of the putative transmembrane domain, the puta-
tive oligomerisation and FtsZ-binding region, and the
PP2C-type phosphatase domain. This fragment was cloned
downstream of a sequence encoding an N-terminal cleavable
hexahistidine tag and upstream and in-frame with a 30
sequence encoding a C-terminal biotin acceptor peptide to be
used as the solubility reporter. The protocol generates a
random library of constructs in which all possible truncations
of the 1581 base pair fragment are expected to be approxi-
mately four-fold oversampled. Following the deletion steps,
agarose gel analysis revealed the expected smear of
linear truncation products across the range defined by the
spoIIE fragment with evidence of some overtruncation
(Supplementary Fig. S1, available at PEDS online). To
reduce the likely dominance of small expression constructs,
prior to DNA re-circularisation, the library was divided into
two insert size ranges by excising appropriate slices. The
‘small’ sublibrary contained vectors with inserts of approxi-
mately 0–750 bp and the ‘large’ sublibrary contained inserts
of approximately 750 bp full length. Following plating, 12
randomly selected clones were analysed by PCR of plasmid
inserts to assess the quality of each sublibrary. All 12 clones
from the large sublibrary gave clear and clean PCR products
with a diversity of sizes. In contrast, for the small sublibrary,
only six of the clones gave clear PCR products, although
with the expected size diversity. In the remainder, the
30-priming site had been deleted by overtruncation.
The pooled sublibraries were used to transform E.coli BL21
(DE3) RIL and 3072 and 6144 colonies, for the large and
small sublibraries, respectively, were picked robotically into
384-well plates containing growth media. Taking account of
the sublibrary efficiency and the fact that each sublibrary may
contain 750 different truncation constructs, this represents
approximately four-fold oversampling of both sublibraries.
A.E.Rawlings et al.
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Colony array screen to enrich putatively soluble constructs
from the library
Clones from each sublibrary were robotically arrayed in dupli-
cate onto nitrocellulose membranes on which colonies were
subsequently grown and the expression of recombinant protein
induced by transferring to agar supplemented with IPTG and
biotin. Putative soluble expression clones were identified by
hybridising membranes with Alexa488 streptavidin to detect
the biotinylated C-terminal tag. Simultaneously, a monoclonal
anti-hexahistidine antibody with associated Alexa532 mouse
secondary antibody was used to detect the N-terminal hexahis-
tidine tag; comparison of this signal with that from streptavi-
din helped eliminate degraded protein constructs, or those
resulting from internal initiation of translation, from the set
selected for further testing.
It was evident that there was a very high number of
clones exhibiting signals from binding of the streptavidin
conjugate especially in the large clone sublibrary (Fig. 2
and Supplementary Fig. S2A, available at PEDS online). In
contrast, the number of clones signalling the hexahistidine
tag was much lower for both sublibraries (Fig. 2 and
Supplementary Fig. S2B, available at PEDS online). To
quantify this analysis, averages of the duplicate biotin and
hexahistidine signal intensities were calculated for each
clone. The signal intensity values were divided into bins and
frequency histograms were plotted (Supplementary Fig. S2C
and D, available at PEDS online). The majority of clones
(.80%) give negligible hexahistidine tag signals in the first
two bins (Supplementary Fig. S2A, available at PEDS
online) with the remaining clones showing a distribution of
intensities that gives rise to a smooth decrease in frequency
over the higher intensity bins. For the biotin array, only
about a third of the clones fall in the low intensity bins,
much less than would be expected given that 66% of the
clones are expected to encode out-of-frame fusions
(Supplementary Fig. S2B, available at PEDS online).
The high number of colonies displaying a biotin signal is
likely due to internal translation initiation that has been
noted previously for SpoIIE (Lucet et al., 2000) when a con-
taminating 28 kDa SpoIIE species was observed in prep-
arations of a 55 ka Da SpoIIE(320–827) fragment. In that
study, Edman degradation revealed a SpoIIE sequence begin-
ning at residue 568 with an amino terminal methionine
replacing the expected Val. The Val568 codon GUG is an
alternative start codon in E.coli, moreover it is preceded
by a purine-rich sequence which may function as a
Shine-Dalgarno box. If these elements do constitute an effi-
cient internal ribosome entry site (IRES), it would explain
the prevalence of biotinylated protein signals in the large
sublibrary designed to express deletants beginning between
residues 300 and 563, relative to the small sublibrary
designed to express shorter truncated proteins with N-termini
between residues 564 and 827.
The background fluorescence intensity values for both
biotin and hexahistidine were subtracted from the averaged
duplicate signals and those clones having a significant posi-
tive hexahistidine signal were then ranked according to their
biotin intensity. The top 96 clones, designated A1–H12,
according to this ranking were selected for further analysis.
Expression trials
The highest signalling 96 constructs were expressed in
small-scale liquid cultures (4 ml) and an aliquot of cells used
directly as template in a rapid PCR screen to assess size
diversity using the flanking T7 promoter and T7 terminator
primers. Gel analysis showed that in the majority of cases
(67 of 96 clones) a single clean PCR fragment was observed
with an apparent cluster at about 1000 bp. Inserts ranged
from 1600 bp down to ,100 bp. Twenty-one of the 96
clones produced no PCR product and eight gave rise to more
than one product; these were not characterised further. The
cells were lysed and the hexahistidine-tagged proteins puri-
fied on Ni2þ-NTA agarose beads using a robotic protocol
(Scheich et al., 2003). Imidazole elution fractions were ana-
lysed by SDS-PAGE revealing only a few clones giving rise
to bands consistent with the overexpression of recombinant
protein, notably clone F4 with an intensely staining band at
25 kDa whose mass was consistent with the PCR fragment
size of 700 bp. Retrospective analysis revealed the absence
of recombinant protein in the soluble lysis fraction for most
clones. A further repeat analysis of total and soluble lysis
fractions from a subset of representative clones with high
ESPRIT array rankings revealed that, where expressed, the
protein was often found in the total fraction and not the
soluble fraction. It seemed possible that during cell lysis
under the neutral pH conditions required for protein purifi-
cation, a hitherto soluble but sensitive protein might aggre-
gate into the insoluble fraction. To investigate this, we
selected a promising clone B2 (from initial trials), and
performed the lysis procedure in 10 different buffers
chosen from a sparse-matrix set (Lindwall et al., 2000;
Supplementary Table S1, available at PEDS online). For
lysis buffers 9 and 10 (Supplementary Table S1 and Fig. S3,
available at PEDS online), which are Tris-buffered at pH 8.2,
the soluble fraction was visibly enriched for the recombinant
SpoIIE fragment.
Identifying clones for scale-up
In view of the low frequency of purifiable clones from the
initial expression trial and indeed the high proportion of
clones failing to express any recombinant protein, the
sequences of the DNA fragments contained in the highest
signalling 48 constructs were determined. This analysis
revealed a disproportionate number of clones (36/48) with
coding sequences out of frame with the N-terminal
Fig. 2. Screening of the truncation library. The fluorescence signals from a
small section of the colony array are shown. The array was probed for the
presence of biotin with a steptavidin-Alexa fluor, which gives a green
fluorescent signal as an indicator of solubility of the clone (left) and for
hexa-histidine with conjugated anti-His6 antibody, which gives a red
fluorescent signal (right). Comparison of the two signals permits screening
out of degraded or truncated constructs.
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hexahistidine tag, despite exhibiting biotinylation in the
colony array, consistent with the observations of possible
internal initiation of translation (discussed earlier), and
explaining the low frequency of purification on Ni2þ-NTA
agarose. The 12 clones with an in-frame spoIIE sequence
showed a diversity of sizes and the encoded protein frag-
ments were mapped onto the SpoIIE primary sequence
(Fig. 3). When arranged according to fragment size, the frag-
ments appeared to cluster, possibly defining inter-domain
segments of the polypeptide.
Site-directed mutagenesis was carried out on the 12 clones
to restore the stop codon at the end of the spoIIE-coding
sequence, thus suppressing the biotin-acceptor peptide.
Small-scale expression experiments were performed in which
the total cell fraction and the soluble and insoluble lysis frac-
tions were analysed. As a result of these experiments two
expressing clones were identified and taken forward for
protein purification, B2 and H1 representing fragments
expected to encompass the phosphatase domain (III) together
with all or part of domain II, respectively. A third promising
clone B1 harboured a fragment encoding residues 592–827
of SpoIIE which span the PP2C phosphatase domain. Our
experience of a closely related clone expressing
SpoIIE(590–810) made in a separate study, prompted us to
construct a composite clone, B10, encoding SpoIIE(590–827)
which expressed higher levels of soluble recombinant protein
than either parent plasmid. Using the data summarised in
Fig. 3, we made a further plasmid harbouring an insert
encoding a B2–B1 fragment of SpoIIE encompassing resi-
dues 375–595. Following its introduction into E.coli BL21
(DE3), this plasmid directs expression of soluble protein.
Scale-up expression and purification
Four SpoIIE fragments, B2 (SpoIIE(375–827)), H1
(SpoIIE(412–827)) B10 (SpoIIE(590–827)) and B2–B1
(SpoIIE(375–595)) were expressed in large-scale cultures
and purified by metal chelation chromatography and gel fil-
tration (see section Experimental procedures). The B2, H1
and B2–B1 proteins eluted in two distinct peaks (data not
shown) from the gel filtration column, the first peak was
associated with the void volume of the column indicating the
presence of soluble aggregates. The second peaks suggested
the presence of lower molecular weight material either
monomers or dimers. For the B2 preparations (data not
shown), the ratio of the height of the peaks in the gel fil-
tration traces varied according to protein concentration and
the age of the sample. As the tendency of the B2 fragment to
aggregate could not be controlled, this fragment was not
pursued further. The lower molecular mass fractions of the
H1 and B2–B1 fragments in contrast were stable and these
proteins were studied further together with the B10 fragment,
which showed no signs of aggregation. As shown in Fig. 4A
and B, the H1, B2–B1 and B10 proteins could be purified to
greater than 95% purity as judged by Coomassie blue stain-
ing of SDS-polyacrylamide gels (Fig. 4A). Further analysis
of the purified proteins on native polyacrylamide gels
showed only a modest degree of heterogeneity, indicating
that all three protein fragments are suitable for biophysical
and structural investigations (Fig. 4B).
Enzyme activity
To test whether the soluble SpoIIE fragments were able to cata-
lyse the dephosphorylation of phosphorylated SpoIIAA
Fig. 3. Mapping soluble SpoIIE constructs onto the primary structure. The sequenced fragments of SpoIIE are represented as black bars. The numbers in bold
script represent the residue numbers of full-length SpoIIE. The fragment identifier and position of the first residue are indicated. Dotted boxes indicate clusters
of similarly sized fragments, representing possible windows of solubility. The approximate domain organisation of SpoIIE inferred from earlier work is
indicated.
Fig. 4. Gel electrophoretic analysis of samples of the purified SpoIIE
fragments. Coomassie blue staining of gels following resolution of the
samples by electrophoresis. (A) 12.5% SDS-polyacrylamide gel. Lanes 1
and 5, low molecular markers (Bio-rad) with masses indicated; lane 2, the
B10 fragment SpoIIE(590–827); lane 3, the H1 fragment SpoIIE(412–827)
and lane 4, the B2–B1 fragment SpoIIE(375–595) and (B) 7.5%
non-denaturing polyacrylamide gel lane 1, Fragment B10; lane 2, Fragment
H1 and lane 3, the B2–B1 fragment.
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(SpoIIAAP), we incubated the SpoIIE H1 and B10 fragments
with SpoIIAA phosphate. We used SpoIIAAP from
B.sphaericus (BspSpoIIAAP), prepared by coexpression of
BspSpoIIAA with its cognate kinase BspSpoIIAB as described
previously (Seavers et al., 2001).BspSpoIIAA and its B.subtilis
orthologue have 64% sequence similarity and 35% sequence
identify with enhanced conservation of the residues that form
the surface surrounding the phosphorylatable serine (Seavers
et al., 2001). The dephosphorylation assay was carried out in
the presence of a large molar excess of BspSpoIIAAP in a
buffer containing 10 mM MnCl2. The products were analysed
by native polyacrylamide gel electrophoresis. As shown in
Fig. 5A for the H1 fragment, the faster migrating SpoIIAAP
(lane 1) species is converted to the slower migrating SpoIIAA
species (lane 2). There is greater conversion to product at the
1:100 molar ratio of H1:SpoIIAAP (lane 3) than at 1:400
(lane 4), though for reasons that are not clear to us, it is
not possible to drive the reaction to completion, a phenomenon
we also observe with the PP2C domain fragment SpoIIE(590–
827) (Fig. 5A, lanes 5 and 6). This may be a manifestation of
the heterologous assay system.
FtsZ Binding
To monitor the binding of the H1 fragment of SpoIIE to
FtsZ, we used a native gel electrophoresis technique. As can
be seen in Fig. 5B, FtsZ migrates essentially as a single
species in 7.5% native polyacrylamide gels and the mobility
of a proportion of the protein is increased in the presence of
1 mM GTP (lanes 1 and 2). There is some heterogeneity in
the SpoIIE H1 sample (lane 3). When the two proteins are
mixed, the pattern of bands resembles the sum of the individ-
ual protein bands and there is no convincing evidence of
FtsZ-SpoIIE interaction, other than the more intense staining
of material that scarcely enters the gel (lane 4). This may be
associated with protein–protein interactions since this low
mobility staining is less intense when these experiments are
repeated with the B10 (PP2C domain) fragment of SpoIIE,
which would not be expected to bind to FtsZ (lanes 5–7).
Fig. 5. Assays of SpoIIE fragments. (A) SpoIIAA-phosphate dephosphorylation by the H1 and B10 fragments monitored by native gel electrophoresis. Lane 1,
SpoIIAAP (5 mg); lane 2, SpoIIAA (5 mg); lanes 3 and 4, SpoIIAAP (5 mg) incubated in the presence of the H1 fragment at 100:1 and 400:1 molar ratios,
respectively; lanes 5 and 6, SpoIIAAP (5 mg) incubated in the presence of the B10 fragment at 100:1 and 400:1 molar ratios, respectively. The conversion of
SpoIIAAP to the lower mobility SpoIIAA species upon incubation with the SpoIIE fragments is evident. (B) Gel mobility shift assay of FtsZ binding by the
H1 and B10 fragments. Lane 1, FtsZ (7 mg); lane 2, FtsZ (7 mg) þ 1 mM GTP; lane 3, SpoIIE H1 fragment (7 mg); lane 4, FtsZ (7 mg) þ SpoIIE H1 (7 mg) þ
1 mM GTP; lane 5, SpoIIE B10 fragment (7 mg); lane 6, FtsZ (7 mg) þ SpoIIE B10 (7 mg) þ 1 mM GTP; lane 7, FtsZ (7 mg) þ 1mM GTP. There is no
mobility shift evident from these gels other than the additional staining of material at the top of lane 4. (C) SEC-MALLS traces of the molecular mass and
differential refractive index (dRI) versus time, of the eluate from a Superdex S200 column. The bold lines give molecular mass of the eluting species
calculated from measurements of the refractive index and the multi-angle laser light scattering. Three traces for the (i) H1 (red), (ii) B10 (green) and (iii) B2–
B1 (blue) fragments are overlaid.
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The apparent absence of interaction of the H1 fragment of
SpoIIE with FtsZ may be due to the fact that the H1 frag-
ment lacks some of the FtsZ-binding determinants or it may
be a limitation of the assay used. In this regard, we were also
unable to demonstrate an interaction with FtsZ using cross-
linking methods or using a gel filtration chromatography
approach described previously (Lucet et al., 2000). The B2–
B1 fragment was not assayed as the same authors reported
that both the central domain and the phosphatase domain are
necessary for FtsZ binding. The assay was however carried
out with the B2 fragment of SpoIIE and no interaction was
seen. Here the failure to show an interaction may be related
to the tendency of this protein to oligomerise.
Quaternary structure determination
The three soluble and stable fragments H1, SpoIIE(412–827);
B2–B1, SpoIIE(375–595) and B10, SpoIIE(590–827) were
analysed by size exclusion chromatography with MALLS to
determine their oligomeric structure (Folta-Stogniew and
Williams, 1999). Representative chromatograms have been
overlaid in Fig. 5C. Each of the fragments exhibits a clear
peak and the molar masses are calculated to be 46.3, 26.3
and 27.5 kDa for SpoIIE(412–827), SpoIIE(375–595) and
SpoIIE(590–827), respectively. The calculated masses are
47.0, 25.3 and 26.5 kDa, respectively. We conclude that all
three fragments are monomeric.
Discussion
Predicting stable, soluble domains of a protein with little
sequence homology to previously characterised domains is a
challenge. Conventional bioinformatics-led approaches in
which small numbers of individual constructs are cloned and
expressed is an expensive and lengthy process which is often
unsuccessful. Recently, library-based strategies have provided
new routes to well expressing, soluble domains (Hart and
Tarendeau, 2006; Prodromou et al., 2007; Savva et al.,
2007). The ESPRIT technique has yielded soluble fragments
of the human influenza virus polymerase subunit PB2, which
resulted in structures from the C-terminal region and the cap-
binding domain (Tarendeau et al., 2007; Guilligay et al.,
2008; Tarendeau et al., 2008). It has also recently been used
to provide stable, protease-resistant domains of CagA from
the pathogenic bacterium Helicobacter pylori (Angelini
et al., 2009).
The presence of a putative IRES (Lucet et al., 2000) made
the identification of the best-expressing clones producing
SpoIIE more difficult. Screening simultaneously for the
C-terminal biotin acceptor peptide and the N-terminal hexa-
histidine tag reduced but did not eliminate this problem.
Production of soluble SpoIIE fragments proved to be highly
sensitive to induction and lysis conditions and many promis-
ing candidate fragments failed at this stage as well as during
purification where latent aggregation problems were encoun-
tered. Nevertheless, through employing ESPRIT to identify
the constructs coupled to subsequent optimisation of down-
stream expression, lysis and purification parameters, we were
able to achieve the principal goal of the study which was pro-
duction of pure, soluble SpoIIE domain fragments. Notably,
SpoIIE(412–827), SpoIIE(375–595) and SpoIIE(590–827)
were obtained in sufficient quantities to initiate and sustain
biophysical and structural studies without the need for deter-
gents or regimes for refolding from inclusion bodies.
Although, only a minority of the highest ranking set of 12
clones expressing soluble protein in vivo led to stable purified
protein in vitro, analysis of this data set is illuminating with
respect to the domain structure of SpoIIE. The soluble con-
structs fall into four clusters A, B, C and D (Fig. 3), according
to the location of their N-termini and these can be thought of
as defining solubility windows. A truncated mutant that is
soluble is more likely to have its N-terminus in a linker region
between domains, than within a domain which may expose the
hydrophobic core, disrupting folding and hence solubility.
Window A spanning residues 321–328 and defined by
fragments G6 and G1, may identify the start of the SpoIIE
cytoplasmic domain with residue 321 predicted to be the
penultimate residue of a tenth putative transmembrane helix
(Arigoni et al., 1999). The 47 residue A–B intervening
sequence has a high a-helical propensity according to the
PredictProtein server (Rost and Liu, 2003). This segment
spans the site of the classic spoIIE48 mutation (S361F)
which blocks sF activity (Barak, 1996; Carniol et al., 2004).
The A–B region may therefore constitute a small domain or
subdomain. Window B, opens at residue 375 and is defined
by fragments B2, A6, H5 and H1 the most compact construct
beginning at position 412 (Fig. 3). The B–C intervening
sequence, residues (412–553), would then constitute a
second domain. The ESPRIT analysis indicates that the
region assigned as the FtsZ binding and oligomerisation
domain in Fig. 1B is partitioned into two soluble domains
with a 40 or so residue linker (Fig. 3).
Window C which encompasses residues 553–592 leads
into the phosphatase domain (Duncan et al., 1995) which
extends to the C-terminus. It is interesting to note that
the putative IRES sequence at residue 568 occurs in window
C, such that the IRES translation product would constitute
a soluble functional domain. This may have functional
relevance although it is not known whether the IRES is
functional in B.subtilis. The fourth window (D) at residues
676–704 is unexpected as it is located within the PP2C
phosphatase region which would be expected to constitute a
stable domain based on the sequence similarity, albeit low
(11%), to the PP2C domain of PstP from Mycobacterium
tuberculosis, whose structure is known (Pullen et al., 2004).
It may be that this window does indeed represent a boundary
between subdomains, alternatively, this fragment may simply
be an unfolded piece of the target whose sequence compo-
sition and size avoids the degradation response in E.coli.
In summary, prior to this study, SpoIIE had not been
expressed at high yields in recombinant form due to difficul-
ties in defining stable constructs around domain boundaries,
largely because no well-characterised homologues exist for
constructing multiple sequence alignments. Here we applied
an empirical, library-based approach comprising a truncation
mutagenesis procedure and a high throughput, two-step
expression screen. Despite minor difficulties due to internal
initiation of translation and the need to optimise buffers and
conditions for downstream steps, the constructs identified by
this directed evolution-type methodology led to the pro-
duction of previously undescribed, highly expressing and
active protein domains. These will be of importance for
structural and functional studies required for understanding
the sporulation mechanism of B.subtilis.
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